Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14940)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2019 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Johnston MP, Khakoo SI. Immunotherapy for hepatocellular carcinoma: Current and future. World J Gastroenterol 2019; 25(24): 2977-2989 [PMID: 31293335 DOI: 10.3748/wjg.v25.i24.2977] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i24/2977.htm |
| Number | Citing Articles |
| 1 |
A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, O. I. Kirsanova, E. V. Lymar. Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibitors. Meditsinskiy sovet = Medical Council 2021; (20): 84 doi: 10.21518/2079-701X-2021-20-84-93
|
| 2 |
Dafeng Xu, Yu Wang, Jincai Wu, Shixun Lin, Yonghai Chen, Jinfang Zheng. Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02326-8
|
| 3 |
Jerry B. Harvey, Luan H. Phan, Oscar E. Villarreal, Jessica L. Bowser. CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00508
|
| 4 |
Erin Bresnahan, Katherine E. Lindblad, Marina Ruiz de Galarreta, Amaia Lujambio. Mouse Models of Oncoimmunology in Hepatocellular Carcinoma. Clinical Cancer Research 2020; 26(20): 5276 doi: 10.1158/1078-0432.CCR-19-2923
|
| 5 |
John C. McVey, Qianfei Zhang, Tim F. Greten, Chi Ma. Inflammation, Infection, and Microbiome in Cancers. Physiology in Health and Disease 2021; : 199 doi: 10.1007/978-3-030-67951-4_7
|
| 6 |
Vibha Sinha, Sapnita Shinde, Vinit Singh Baghel, Naveen Kumar Vishvakarma, Dhananjay Shukla, Atul Kumar Tiwari, Ashwini Kumar Dixit, Sanjay Kumar Pandey, Sudhakar Dwivedi, Mrinalini Singh, Vineeta Dixit. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 43 doi: 10.1016/B978-0-323-99283-1.00018-5
|
| 7 |
Dhatri Madduru, Ngalah Bidii Stephen, Urvashi Vijay, Pranathi Pappu, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 225 doi: 10.1016/B978-0-323-99283-1.00021-5
|
| 8 |
Wei Huang, Jia Mei, Yuan-Jie Liu, Jie-Pin Li, Xi Zou, Xiao-Ping Qian, Yu Zhang. An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC). Journal of Hepatocellular Carcinoma 2023; : 497 doi: 10.2147/JHC.S404396
|
| 9 |
Yash Jani, Caroline S Jansen, Margo B Gerke, Mehmet Asim Bilen. Established and emerging biomarkers of immunotherapy in renal cell carcinoma. Immunotherapy 2024; 16(6): 405 doi: 10.2217/imt-2023-0267
|
| 10 |
Honghong Shen, Xianhua Gu, Huiyuan Li, Mingyue Tang, Xinwei Li, Yue Zhang, Fang Su, Zishu Wang. Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model. Journal of Hepatocellular Carcinoma 2023; : 327 doi: 10.2147/JHC.S398713
|
| 11 |
Long Yang, Haohui Zhu, Xijun Zhang, Xiaobing Fu, Xiaojuan Zhao, Xiaojing Wang, Xiaozhuan Ren, Haibo Yu, Jianjun Yuan. Evaluation of hepatic functional reserve of hepatocellular carcinoma (≤ 5 cm) by liver shear wave velocity combined with multiple parameters. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1301052
|
| 12 |
Kumar Jayant, Nagy Habib, Kai W. Huang, Mauro Podda, Jane Warwick, Ramesh Arasaradnam. Immunological Basis of Genesis of Hepatocellular Carcinoma: Unique Challenges and Potential Opportunities through Immunomodulation. Vaccines 2020; 8(2): 247 doi: 10.3390/vaccines8020247
|
| 13 |
Qingzhu Jia, Han Chu, Zheng Jin, Haixia Long, Bo Zhu. High-throughput single-сell sequencing in cancer research. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-00990-4
|
| 14 |
Xi Li, S. Ali Montazeri, Ricardo Paz-Fumagalli, Carlos A. Padula, Weiping Wang, Kabir Mody, Lewis R. Roberts, Tushar Patel, Sunil Krishnan, Beau Toskich. Prognostic Significance of Neutrophil to Lymphocyte Ratio Dynamics in Patients with Hepatocellular Carcinoma Treated with Radioembolization Using Glass Microspheres. European Journal of Nuclear Medicine and Molecular Imaging 2021; 48(8): 2624 doi: 10.1007/s00259-020-05186-y
|
| 15 |
Fei Lu, Xiao-Jing-Nan Ma, Wei-Lin Jin, Yang Luo, Xun Li. Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and Challenges. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.690565
|
| 16 |
Shu-Ling Chen, Chia-Ying Ho, Wei-Chun Lin, Chao-Wei Lee, Yu-Chun Chen, Jiun-Liang Chen, Hsing-Yu Chen. The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core Herbs. International Journal of Environmental Research and Public Health 2022; 19(19): 12480 doi: 10.3390/ijerph191912480
|
| 17 |
Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David James Pinato, Lorenza Rimassa. Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?. Therapeutic Advances in Medical Oncology 2023; 15: 175883592211480 doi: 10.1177/17588359221148029
|
| 18 |
Yetirajam Rajesh, Devanand Sarkar. Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma. Cancers 2020; 12(5): 1290 doi: 10.3390/cancers12051290
|
| 19 |
Qun Cai, Mingyan Zhu, Jinnan Duan, Hao Wang, Jingdan Chen, Yixin Xiao, Yangqin Wang, Jianfang Wang, Xuewen Yu, Hui Yang. Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.786873
|
| 20 |
Linjun Liang, Xiaoyan Wang, Shuying Huang, Yanwei Chen, Peng Zhang, Liang Li, Yong Cui. Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1046771
|
| 21 |
Mohammed Abdul-Latif, Katherine Townsend, Charles Dearman, Kai-Keen Shiu, Khurum Khan. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives. Cancer Treatment Reviews 2020; 88: 102030 doi: 10.1016/j.ctrv.2020.102030
|
| 22 |
Shvetank Bhatt, Jovita Kanoujia, Arghya K. Dhar, Rakesh K. Singh, Jayaraman Rajangam. Current and Future Scenario of Immunotherapy for the Treatment of Hepatocellular Carcinoma. Current Cancer Therapy Reviews 2021; 17(2): 148 doi: 10.2174/1573394716999200818103724
|
| 23 |
Jihao Cai, Minglei Zhou, Jianxin Xu. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02354-8
|
| 24 |
Kumar Jayant, Nagy Habib, Kai W. Huang, Jane Warwick, Ramesh Arasaradnam. Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma. Diagnostics 2020; 10(5): 338 doi: 10.3390/diagnostics10050338
|
| 25 |
Sai Swarupa R Vulasala, Nirmal K Onteddu, Sindhu P Kumar, Chandana Lall, Priya Bhosale, Mayur K Virarkar. Advances and effectiveness of the immunotherapy after liver transplantation. World Journal of Gastrointestinal Surgery 2022; 14(6): 629-631 doi: 10.4240/wjgs.v14.i6.629
|
| 26 |
Paola De Cicco, Giuseppe Ercolano, Angela Ianaro. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01680
|
| 27 |
Daniele Fanale, Lidia Rita Corsini, Raimondo Scalia, Chiara Brando, Alessandra Cucinella, Giorgio Madonia, Alessandra Dimino, Clarissa Filorizzo, Nadia Barraco, Marco Bono, Alessia Fiorino, Luigi Magrin, Roberta Sciacchitano, Alessandro Perez, Tancredi Didier Bazan Russo, Gianni Pantuso, Antonio Russo, Viviana Bazan. Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?. Critical Reviews in Oncology/Hematology 2022; 170: 103597 doi: 10.1016/j.critrevonc.2022.103597
|
| 28 |
Aswathy R. Devan, Ayana R. Kumar, Bhagyalakshmi Nair, Nikhil Ponnoor Anto, Amitha Muraleedharan, Bijo Mathew, Hoon Kim, Lekshmi R. Nath. Insights into an Immunotherapeutic Approach to Combat Multidrug Resistance in Hepatocellular Carcinoma. Pharmaceuticals 2021; 14(7): 656 doi: 10.3390/ph14070656
|
| 29 |
Bingfeng Zuo, Yang Zhang, Kangjie Zhao, Li Wu, Han Qi, Rong Yang, Xianjun Gao, Mengyuan Geng, Yingjie Wu, Renwei Jing, Qibing Zhou, Yiqi Seow, HaiFang Yin. Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses. Journal of Hematology & Oncology 2022; 15(1) doi: 10.1186/s13045-022-01266-8
|
| 30 |
Ming-Cheng Guan, Ming-Da Wang, Si-Yu Liu, Wei Ouyang, Lei Liang, Timothy M Pawlik, Qiu-Ran Xu, Dong-Sheng Huang, Feng Shen, Hong Zhu, Tian Yang. Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside. World Journal of Gastrointestinal Oncology 2021; 13(4): 197-215 doi: 10.4251/wjgo.v13.i4.197
|
| 31 |
Sidra Zafar, Baogang Bai, Jinlei Guo, Syed Aun Muhammad, Syeda Tahira Qousain Naqvi, Muhammad Nauman Shabbir, Imran Imran, Rehan Sadiq Shaikh, Amjad Ali, Bing Niu. Experimental Study of Potential CD8+ Trivalent Synthetic Peptides for Liver Cancer Vaccine Development Using Sprague Dawley Rat Models. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4792374
|
| 32 |
Fei Kong, Meishan Jin, Donghui Cao, Zhifang Jia, Yawen Liu, Jing Jiang. Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma. PeerJ 2020; 8: e9949 doi: 10.7717/peerj.9949
|
| 33 |
Yi Wang, Na Li, Di Tian, Chang-Wu Zhou, You-Hua Wang, Chun Yang, Meng-Su Zeng. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma. Cancer Management and Research 2021; : 6451 doi: 10.2147/CMAR.S322179
|
| 34 |
Xiaopu Sang, Fenfang Wu, Di Wu, Shan Lin, Jingyi Li, Nan Zhao, Xiaoni Chen, Anlong Xu. Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00112
|
| 35 |
Cheng-Maw Ho, Rey-Heng Hu, Yao-Ming Wu, Ming-Chih Ho, Po-Huang Lee. Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation. Clinical Medicine Insights: Oncology 2020; 14: 117955492096877 doi: 10.1177/1179554920968774
|
| 36 |
Lucile Dumolard, Julien Ghelfi, Gael Roth, Thomas Decaens, Zuzana Macek Jilkova. Percutaneous Ablation-Induced Immunomodulation in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(12): 4398 doi: 10.3390/ijms21124398
|
| 37 |
Daolin Zeng, Chunlin Yu, Shiyao Chen, Long Zou, Junjun Chen, Linlong Xu. Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer. World Journal of Surgical Oncology 2024; 22(1) doi: 10.1186/s12957-024-03364-y
|
| 38 |
宇 郭. Progress in the Treatment of Hepatocellular Carcinoma Based on Hepatic Arterial Infusion Chemotherapy. Advances in Clinical Medicine 2022; 12(01): 587 doi: 10.12677/ACM.2022.121087
|
| 39 |
Carmelo Laface, Palma Fedele, Felicia Maria Maselli, Francesca Ambrogio, Caterina Foti, Pasquale Molinari, Michele Ammendola, Marco Lioce, Girolamo Ranieri. Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities. Cancers 2022; 14(16): 4028 doi: 10.3390/cancers14164028
|
| 40 |
Chun Chau Lawrence Cheung, Yong Hock Justin Seah, Juntao Fang, Nicole Hyacinth Calpatura Orpilla, Mai Chan Lau, Chun Jye Lim, Xinru Lim, Justina Nadia Li Wen Lee, Jeffrey Chun Tatt Lim, Sherlly Lim, Qing Cheng, Han Chong Toh, Su Pin Choo, Suat Ying Lee, Joycelyn Jie Xin Lee, Jin Liu, Tony Kiat Hon Lim, David Tai, Joe Yeong. Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1150985
|
| 41 |
Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair, Reshma Ravindran Nair, Lekshmi R. Nath. Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular Carcinoma. Current Cancer Drug Targets 2022; 22(9): 725 doi: 10.2174/1568009622666220317090552
|
| 42 |
Wen Yin, Xingjun Jiang, Jun Tan, Zhaoqi Xin, Quanwei Zhou, Chaohong Zhan, Xianyong Fu, Zhaoping Wu, Youwei Guo, Zhipeng Jiang, Caiping Ren, Guihua Tang. Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01409
|
| 43 |
Wentao Jia, Lina Wang. Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/9843486
|
| 44 |
Fuat Bicer, Catrina Kure, Anil A. Ozluk, Bassel F. El-Rayes, Mehmet Akce. Advances in Immunotherapy for Hepatocellular Carcinoma (HCC). Current Oncology 2023; 30(11): 9789 doi: 10.3390/curroncol30110711
|
| 45 |
Zhen Zhao, Baoping Zheng, Jianglin Zheng, Yi Zhang, Cheng Jiang, Chuansheng Nie, Xiaobing Jiang, Dongxiao Yao, Hongyang Zhao. Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma. Journal of Molecular Neuroscience 2023; 73(7-8): 608 doi: 10.1007/s12031-023-02142-x
|
| 46 |
Adam Swersky, Laura Kulik, Aparna Kalyan, Karen Grace, Juan Carlos Caicedo, Robert J. Lewandowski, Riad Salem. Contemporary Algorithm for the Management of Hepatocellular Carcinoma in 2021: The Northwestern Approach. Seminars in Interventional Radiology 2021; 38(04): 432 doi: 10.1055/s-0041-1735528
|
| 47 |
SalehA Alqahtani, FaisalM Sanai, Ashwaq Alolayan, Faisal Abaalkhail, Hamad Alsuhaibani, Mazen Hassanain, Waleed Alhazzani, Abdullah Alsuhaibani, Abdullah Algarni, Alejandro Forner, RichardS Finn, WaleedK Al-hamoudi. Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma. Saudi Journal of Gastroenterology 2020; 26(7): 1 doi: 10.4103/sjg.SJG_477_20
|
| 48 |
Liu Yang, Long-fei Zeng, Guo-qing Hong, Qing Luo, Xing Lai, Fu Wang. Construction of a Novel Clinical Stage-Related Gene Signature for Predicting Outcome and Immune Response in Hepatocellular Carcinoma. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/6535009
|
| 49 |
Qianhui Chen, Xinyu Lu, Jiayi Xie, Na Ma, Weikang Xu, Zhiming Zhang, Xuan Huang, Hongyan Liu, Jinlin Hou, Xiaoyong Zhang, Wei Zhu. Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.813275
|
| 50 |
Yanlin Du, Da Zhang, Yiru Wang, Ming Wu, Cuilin Zhang, Youshi Zheng, Aixian Zheng, Xiaolong Liu. A highly stable multifunctional aptamer for enhancing antitumor immunity against hepatocellular carcinoma by blocking dual immune checkpoints. Biomaterials Science 2021; 9(11): 4159 doi: 10.1039/D0BM02210A
|
| 51 |
Chen Xue, Xinyu Gu, Yalei Zhao, Junjun Jia, Qiuxian Zheng, Yuanshuai Su, Zhengyi Bao, Juan Lu, Lanjuan Li. Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02730-8
|
| 52 |
Rohini Sharma, Leila Motedayen Aval. Beyond First-Line Immune Checkpoint Inhibitor Therapy in Patients With Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.652007
|
| 53 |
Keren Rouvinov, Gal Mazor, Ella Kozlener, Amichay Meirovitz, Noa Shani Shrem, Omar Abu Saleh, Sondos Shalata, Alexander Yakobson, Walid Shalata. Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience. Journal of Personalized Medicine 2023; 13(11): 1623 doi: 10.3390/jpm13111623
|
| 54 |
Wanbang Zhou, Yiyang Chen, Ruixing Luo, Zifan Li, Guanwei Jiang, Xi Ou. Identification of Biomarkers Related to Immune Cell Infiltration in Hepatocellular Carcinoma Using Gene Co-Expression Network. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.601693
|
| 55 |
Yanan Wang, Boshizhang Peng, Chun Ning, Shuya He, Huayu Yang, Yilei Mao, Lejia Sun. Characterization of immune features and immunotherapy response in subtypes of hepatocellular carcinoma based on mitophagy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.966167
|
| 56 |
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh, Mathias Heikenwalder. Liver Inflammation and Hepatobiliary Cancers. Trends in Cancer 2021; 7(7): 606 doi: 10.1016/j.trecan.2021.01.012
|
| 57 |
Chunchen Wu, She Tian, Yuting Guo, Chao Yu, Linhan Lei, Dijie Zheng, Huahua Xie, Jian Zheng, Chengyi Sun, Fu Wang. circACTG1 Promotes Hepatocellular Carcinoma Progression by Regulating miR-940/RIF1 Axis and Activating AKT/mTOR Pathway. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/8649386
|
| 58 |
Debashri Manna, Devanand Sarkar. Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma. Cancers 2020; 12(5): 1243 doi: 10.3390/cancers12051243
|
| 59 |
Qian Li, Fei Ma, Ju feng Wang. Advanced lung cancer inflammation index predicts survival outcomes of hepatocellular carcinoma patients receiving immunotherapy. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.997314
|
| 60 |
Hung-Wei Cheng, Yu-Ling Ou, Chia-Chi Kuo, Hsin-Yi Tsao, Huai-En Lu. Ansamitocin P3-Loaded Gold-NanoCage Conjugated with Immune Checkpoint Inhibitor to Enhance Photo-Chemo-Thermal Maturation of Dendritic Cells for Hepatocellular Carcinoma. Polymers 2021; 13(16): 2726 doi: 10.3390/polym13162726
|
| 61 |
Rui Wang, Hui Guo, Xiaotong Tang, Tiantian Zhang, Yang Liu, Cheng Zhang, Hanbing Yu, Yumei Li. Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells. Inflammation 2022; 45(1): 308 doi: 10.1007/s10753-021-01547-3
|
| 62 |
Neehar D Parikh, Alexander Marshall, Keith A Betts, Jinlin Song, Jing Zhao, Muhan Yuan, Aozhou Wu, Keith D Huff, Richard Kim. Network meta-analysis of nivolumab plus ipilimumab in the second-line setting for advanced hepatocellular carcinoma. Journal of Comparative Effectiveness Research 2021; 10(5): 343 doi: 10.2217/cer-2020-0236
|
| 63 |
Ningning Liu, Clifford J. Steer, Guisheng Song. MicroRNA‐206 enhances antitumor immunity by disrupting the communication between malignant hepatocytes and regulatory T cells in c‐Myc mice. Hepatology 2022; 76(1): 32 doi: 10.1002/hep.32182
|
| 64 |
Nicolò Brandi, Matteo Renzulli. The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(10): 8598 doi: 10.3390/ijms24108598
|
| 65 |
Yue Chen, Haoyue Hu, Xianglei Yuan, Xue Fan, Chengda Zhang. Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.896752
|
| 66 |
Farzam Vaziri, Steven D. Colquhoun, Yu-Jui Yvonne Wan. Hepatocellular carcinoma immunotherapy: The impact of epigenetic drugs and the gut microbiome. Liver Research 2020; 4(4): 191 doi: 10.1016/j.livres.2020.10.001
|
| 67 |
Thuzar Hla Shwe, Peraphan Pothacharoen, Thanyaluck Phitak, Benjawan Wudtiwai, Prachya Kongtawelert. Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences 2021; 22(16): 8755 doi: 10.3390/ijms22168755
|
| 68 |
Zhangya Pu, Jinghua Liu, Zelong Liu, Fang Peng, Yuanyuan Zhu, Xiaofang Wang, Jiayan He, Panpan Yi, Xingwang Hu, Xuegong Fan, Jiang Chen. STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02734-4
|
| 69 |
Diwakar Suresh, Akshatha N. Srinivas, Akila Prashant, Kuzhuvelil B. Harikumar, Divya P. Kumar. Therapeutic options in hepatocellular carcinoma: a comprehensive review. Clinical and Experimental Medicine 2023; 23(6): 1901 doi: 10.1007/s10238-023-01014-3
|
| 70 |
Senbang Yao, Wenjun Chen, Tingting Chen, He Zuo, Ziran Bi, Xiuqing Zhang, Lulian Pang, Yanyan Jing, Xiangxiang Yin, Huaidong Cheng. A comprehensive computational analysis to explore the importance of SIGLECs in HCC biology. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02672-z
|
| 71 |
Alessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, Giovanni Brandi. First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges. Expert Review of Gastroenterology & Hepatology 2021; 15(11): 1245 doi: 10.1080/17474124.2021.1973431
|
| 72 |
Ievgen V. Pylypchuk, Huizhen Suo, Chanakarn Chucheepchuenkamol, Nils Jedicke, Pär A. Lindén, Mikael E. Lindström, Michael P. Manns, Olena Sevastyanova, Tetyana Yevsa. High-Molecular-Weight Fractions of Spruce and Eucalyptus Lignin as a Perspective Nanoparticle-Based Platform for a Therapy Delivery in Liver Cancer. Frontiers in Bioengineering and Biotechnology 2022; 9 doi: 10.3389/fbioe.2021.817768
|
| 73 |
Pan Huang, Yi-dou Hu, Yuan-jie Liu, Jie-pin Li, Yong-hua Zhang. An Analysis Regarding the Association Between the Nuclear Pore Complex (NPC) and Hepatocellular Carcinoma (HCC). Journal of Hepatocellular Carcinoma 2023; : 959 doi: 10.2147/JHC.S417501
|
| 74 |
Yifan Lu, Songhai Chen, Qingqing Wang, Jie Zhang, Xuanzeng Pei, Jinghua Pan. PRR7-AS1 Correlates with Immune Cell Infiltration and Is a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1939368
|
| 75 |
Igor V. Komarov, Ganna Tolstanova, Halyna Kuznietsova, Natalia Dziubenko, Petro I. Yanchuk, Lydia Y. Shtanova, Stanislav P. Veselsky, Liudmyla V. Garmanchuk, Nataliia Khranovska, Oleksandr Gorbach, Taisa Dovbynchuk, Petro Borysko, Oleg Babii, Tim Schober, Anne S. Ulrich, Sergii Afonin. Towards in vivo photomediated delivery of anticancer peptides: Insights from pharmacokinetic and -dynamic data. Journal of Photochemistry and Photobiology B: Biology 2022; 233: 112479 doi: 10.1016/j.jphotobiol.2022.112479
|
| 76 |
Xinhui Shi, Qisong Li, Yungang Wang. Impact of regulatory T cells on the prognosis of hepatocellular carcinoma. Medicine 2021; 100(3): e23957 doi: 10.1097/MD.0000000000023957
|
| 77 |
Zakaria Mohamed Alghzzawy, Tarek Khaled Elmaghraby, Sanaa Abd El-Hamid Hagag, Mohammed Hussein Awwad. Combretastatin A-4 disodium phosphate and low dose gamma irradiation suppress hepatocellular carcinoma by downregulating ROCK1 and VEGF gene expression. Molecular Biology Reports 2020; 47(3): 1883 doi: 10.1007/s11033-020-05282-0
|
| 78 |
Xiu-Mei Bai, Zhong-Hu He, Hao Wu, Wei Yang, Song Wang, Zhong-Yi Zhang, Wei Wu, Kun Yan, Min-Hua Chen, S. Nahum Goldberg. An evaluation of 20-year survival of radiofrequency ablation for hepatocellular carcinoma as first-line treatment. European Journal of Radiology 2023; 168: 111094 doi: 10.1016/j.ejrad.2023.111094
|
| 79 |
Isabella Lurje, Linda Hammerich, Frank Tacke. Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer. International Journal of Molecular Sciences 2020; 21(19): 7378 doi: 10.3390/ijms21197378
|
| 80 |
Jiejun Hu, Dong Cai, Zhibo Zhao, Guo-Chao Zhong, Jianping Gong. Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.659676
|
| 81 |
Mark Farha, Neil K. Jairath, Theodore S. Lawrence, Issam El Naqa. Characterization of the Tumor Immune Microenvironment Identifies M0 Macrophage-Enriched Cluster as a Poor Prognostic Factor in Hepatocellular Carcinoma. JCO Clinical Cancer Informatics 2020; (4): 1002 doi: 10.1200/CCI.20.00077
|
| 82 |
Alessandra Bertacco, Alessandro Vitale, Claudia Mescoli, Umberto Cillo. Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resection. Personalized Medicine 2020; 17(2): 83 doi: 10.2217/pme-2018-0114
|
| 83 |
Luca Rinaldi, Erica Vetrano, Barbara Rinaldi, Raffaele Galiero, Alfredo Caturano, Teresa Salvatore, Ferdinando Carlo Sasso. HCC and Molecular Targeting Therapies: Back to the Future. Biomedicines 2021; 9(10): 1345 doi: 10.3390/biomedicines9101345
|
| 84 |
Qiuyue Zhang, Jinchen Liu, Haifeng Lin, Bo Lin, Mingyue Zhu, Mengsen Li. Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells. Exploration of Targeted Anti-tumor Therapy 2023; : 519 doi: 10.37349/etat.2023.00149
|
| 85 |
Ningning Liu, Xiaomei Wang, Clifford John Steer, Guisheng Song. MicroRNA-206 promotes the recruitment of CD8+ T cells by driving M1 polarisation of Kupffer cells. Gut 2021; : gutjnl-2021-324170 doi: 10.1136/gutjnl-2021-324170
|
| 86 |
Sushrut Kamerkar, Charan Leng, Olga Burenkova, Su Chul Jang, Christine McCoy, Kelvin Zhang, Kevin Dooley, Samuel Kasera, Tong Zi, Sílvia Sisó, William Dahlberg, Chang Ling Sia, Shil Patel, Karl Schmidt, Kyriakos Economides, Timothy Soos, Dalia Burzyn, Sriram Sathyanarayanan. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity. Science Advances 2022; 8(7) doi: 10.1126/sciadv.abj7002
|
| 87 |
Utibe-Abasi Udoh, Juan D Sanabria, Pradeep K Rajan, Moumita Banerjee, Mathew Schade, Jacqueline A Sanabria, Gary Smith, Gideon Udoh, Komal Sodhi, Sandrine Pierre, Joseph I Shapiro, Juan R Sanabria. Liver Cancer. 2021; : 55 doi: 10.36255/exonpublications.livercancer.2021.ch3
|
| 88 |
Puneeth Guruprasad, Yong Gu Lee, Ki Hyun Kim, Marco Ruella. The current landscape of single-cell transcriptomics for cancer immunotherapy. Journal of Experimental Medicine 2021; 218(1) doi: 10.1084/jem.20201574
|
| 89 |
Zhen Lin, Yi-Zhao Xie, Ming-Chun Zhao, Pin-Pin Hou, Juan Tang, Guang-Liang Chen. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02173-7
|
| 90 |
Rokas Stulpinas, Dovile Zilenaite-Petrulaitiene, Allan Rasmusson, Aiste Gulla, Agne Grigonyte, Kestutis Strupas, Arvydas Laurinavicius. Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples. Cancers 2023; 15(2): 366 doi: 10.3390/cancers15020366
|
| 91 |
Davide De Battista, Fausto Zamboni, Hannah Gerstein, Shinya Sato, Tovah E Markowitz, Justin Lack, Ronald E Engle, Patrizia Farci. Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC. Journal of Hepatocellular Carcinoma 2021; : 1399 doi: 10.2147/JHC.S325959
|
| 92 |
Kai Dai, Yin Wu, Sha She, Qian Zhang. Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2021; 13(12): 2029-2037 doi: 10.4251/wjgo.v13.i12.2029
Abstract(281) |
Core Tip(327) |
Full Article(HTML)(1951)
|
Full Article (PDF)-662K(242)
|
Full Article (Word)-162K(113)
|
Audio-551K(3)
|
Peer-Review Report-307K(56)
|
Answering Reviewers-145K(49)
|
Times Cited (0)
|
Total Visits (4592)
|
Open
|
| 93 |
Liang Sun, Shian Yu, Cairong Dong, Zhengyi Wu, He Huang, Zhendong Chen, Zhipeng Wu, Xiangbao Yin. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.913398
|
| 94 |
Ying-Zhe Luo, Hong Zhu. Immunotherapy for advanced or recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2023; 15(3): 405-424 doi: 10.4251/wjgo.v15.i3.405
Abstract(243) |
Core Tip(215) |
Full Article(HTML)(1713)
|
Full Article (PDF)-3180K(119)
|
Full Article (Word)-369K(33)
|
Audio-500K(6)
|
Peer-Review Report-238K(22)
|
Answering Reviewers-259K(24)
|
Times Cited (0)
|
Total Visits (3874)
|
Open
|
| 95 |
Xuefeng Kan, Guanhui Zhou, Feng Zhang, Hongxiu Ji, David S Shin, Wayne Monsky, Chuansheng Zheng, Xiaoming Yang. Enhanced efficacy of direct immunochemotherapy for hepatic cancer with image-guided intratumoral radiofrequency hyperthermia. Journal for ImmunoTherapy of Cancer 2022; 10(11): e005619 doi: 10.1136/jitc-2022-005619
|
| 96 |
Hanjuan Gong, Hailun Xie, Zhimin Huangfu, Shuxian Zhang, Yi Tang, Ming Xiao, Ming Li, Yalan Wang. RHBDF2 is correlated with immune infiltrates in hepatocellular carcinoma and may have potential as a biomarker. FEBS Open Bio 2023; 13(5): 881 doi: 10.1002/2211-5463.13598
|
| 97 |
Sandra Mirie Kang, Lana Khalil, Bassel F. El-Rayes, Mehmet Akce. Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.821903
|
| 98 |
Guobo Xie, Yinting Zhu, Zhiyi Lin, Yuping Sun, Guosheng Gu, Weiming Wang, Hui Chen. HOPMCLDA: predicting lncRNA–disease associations based on high-order proximity and matrix completion. Molecular Omics 2021; 17(5): 760 doi: 10.1039/D1MO00138H
|
| 99 |
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang, Hong-Wei Cheng. Engineering nanotheranostic strategies for liver cancer. World Journal of Gastrointestinal Oncology 2021; 13(10): 1213-1228 doi: 10.4251/wjgo.v13.i10.1213
|
| 100 |
Xin Liu, Ziyue Zeng, Jianlei Cao, Xianqing Li, Muheremu Muhetaer, Zhili Jin, Huanhuan Cai, Zhibing Lu. Sintilimab-Induced Myocarditis in a Patient with Gastric Cancer: A Case Report and Literature Review. Journal of Cardiovascular Development and Disease 2023; 10(10): 422 doi: 10.3390/jcdd10100422
|
| 101 |
Bryan Mckiver, Mohamad Imad Damaj, Devanand Sarkar. Assessment of Current Gene Therapy Practices in Hepatocellular Carcinoma. Gastrointestinal Disorders 2020; 2(4): 469 doi: 10.3390/gidisord2040042
|
| 102 |
Margot T.M. Reinders, Karel J. van Erpecum, Maarten L.J. Smits, Arthur J.A.T. Braat, Joep de Bruijne, Rutger Bruijnen, Dave Sprengers, Robert A. de Man, Erik Vegt, Jan N.M. IJzermans, Adriaan Moelker, Marnix G.E.H. Lam. Safety and Efficacy of166Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study. Journal of Nuclear Medicine 2022; 63(12): 1891 doi: 10.2967/jnumed.122.263823
|
| 103 |
Yi Hu, Dan Chen, Minjing Hong, Jing Liu, Yijia Li, Jianlei Hao, Ligong Lu, Zhinan Yin, Yangzhe Wu. Apoptosis, Pyroptosis, and Ferroptosis Conspiringly Induce Immunosuppressive Hepatocellular Carcinoma Microenvironment and γδ T-Cell Imbalance. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.845974
|
| 104 |
Tiantian Lai, Xiaowen Su, Enhong Chen, Yue Tao, Shuo Zhang, Leisheng Wang, Yong Mao, Hao Hu. The DEAD-box RNA helicase, DDX60, Suppresses immunotherapy and promotes malignant progression of pancreatic cancer. Biochemistry and Biophysics Reports 2023; 34: 101488 doi: 10.1016/j.bbrep.2023.101488
|
| 105 |
Linfeng Xu, Xingxing Jian, Zhenhao Liu, Jingjing Zhao, Siwen Zhang, Yong Lin, Lu Xie. Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.741226
|
| 106 |
Kexin Li, Ashley Zhang, Xiaoya Li, Hongtao Zhang, Lianmei Zhao. Advances in clinical immunotherapy for gastric cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(2): 188615 doi: 10.1016/j.bbcan.2021.188615
|
| 107 |
Lin Yu, Nan Huang, Heng Sun, Xi Yang, Yuna Fu, Qiaoli Lang, Jianhua Wang, Liangpeng Ge. Development of a Tetravalent T-Cell Engaging Bispecific Antibody Against Glypican-3 for Hepatocellular Carcinoma. Journal of Immunotherapy 2021; 44(3): 106 doi: 10.1097/CJI.0000000000000349
|
| 108 |
Qiuyu Zhuang, Binyu Zhao, Zhiwen Lin, Yuzhi Liang, Qingfu Zhao, Yunhao Wang, Naishun Liao, Haibin Tu, Youshi Zheng, Hengkai Chen, Yongyi Zeng, Da Zhang, Xiaolong Liu. Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogel. Communications Biology 2023; 6(1) doi: 10.1038/s42003-023-04983-z
|
| 109 |
Ming Yang, Tao Yu, Li Han. Hsa_circ_0010882 facilitates hepatocellular carcinoma progression by modulating M1/M2 macrophage polarization. Journal of Viral Hepatitis 2024; 31(4): 189 doi: 10.1111/jvh.13917
|
| 110 |
Thomas De Somer, Erik Vanderstraeten, Vincent Bouderez, Els Monsaert, Christophe Van Steenkiste. Resolution of a hepatoduodenal fistula after nivolumab treatment in a patient with hepatocellular carcinoma: challenges in immunotherapy. Acta Clinica Belgica 2022; 77(1): 108 doi: 10.1080/17843286.2020.1778346
|
| 111 |
Shao-Ru Liu, Qing Yan, Hao-Ming Lin, Guang-Zi Shi, Yi Cao, Hong Zeng, Chao Liu, Rui Zhang. Anti-programmed cell death ligand 1-based immunotherapy in recurrent hepatocellular carcinoma with inferior vena cava tumor thrombus and metastasis: Three case reports. World Journal of Clinical Cases 2021; 9(21): 5988-5998 doi: 10.12998/wjcc.v9.i21.5988
|
| 112 |
Andreas Koulouris, Christos Tsagkaris, Michail Nikolaou. Real Impact of Novel Immunotherapy Drugs in Cancer. The Experience of 10 Last Years. Toxins 2021; 13(2): 149 doi: 10.3390/toxins13020149
|
| 113 |
Sanghwa Kim, Minji Lee, Yeonhwa Song, Su-Yeon Lee, Inhee Choi, I-Seul Park, Jiho Kim, Jin-sun Kim, Kang mo Kim, Haeng Ran Seo. Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-01912-y
|
| 114 |
Vikrant Rai, Sandeep Mukherjee. Targets of immunotherapy for hepatocellular carcinoma: An update. World Journal of Hepatology 2022; 14(1): 140-157 doi: 10.4254/wjh.v14.i1.140
|
| 115 |
Abhishek Kumar, Florian Pecquenard, Martha Baydoun, Alexandre Quilbé, Olivier Moralès, Bertrand Leroux, Lynda Aoudjehane, Filomena Conti, Emmanuel Boleslawski, Nadira Delhem. An Efficient 5-Aminolevulinic Acid Photodynamic Therapy Treatment for Human Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(13): 10426 doi: 10.3390/ijms241310426
|
| 116 |
Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, Gabriel Bacil Prata, Bart Vanderborght, Tereza Cristina da Silva, Luís Fernando Barbisan, Wellington Andraus, Lindsey Devisscher, Niels Olsen Saraiva Câmara, Mathieu Vinken, Bruno Cogliati. In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling. Cancers 2021; 13(21): 5583 doi: 10.3390/cancers13215583
|
| 117 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Eleni Karapedi, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives. International Journal of Molecular Sciences 2022; 23(12): 6664 doi: 10.3390/ijms23126664
|
| 118 |
Biao Gao, Yafei Wang, Shichun Lu. Construction and validation of a novel signature based on epithelial-mesenchymal transition–related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment. Functional & Integrative Genomics 2023; 23(1) doi: 10.1007/s10142-022-00933-w
|
| 119 |
Wei Wang, Bo Sun, Yang Xia, Shenghong Sun, Chiyi He. RNA N6-Methyladenosine-Related Gene Contribute to Clinical Prognostic Impact on Patients With Liver Cancer. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00306
|
| 120 |
Zhi-Wei Xu. Gene mining of immune microenvironment in hepatocellular carcinoma. Medicine 2022; 101(35): e30453 doi: 10.1097/MD.0000000000030453
|
| 121 |
Ying-jie Gao, Shi-rong Li, Yuan Huang. An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1118152
|
| 122 |
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, Marcel Silva Luz, João Victor Silva Souza, Samuel Luca Rocha Pinheiro, Wedja Rafaela de Souza, Matheus Sande Loureiro, Fabrício Freire de Melo. Oncolytic virus therapy in cancer: A current review. World Journal of Virology 2021; 10(5): 229-255 doi: 10.5501/wjv.v10.i5.229
|
| 123 |
Zhou Lu, Ronghua Liu, Yining Wang, Mengxia Jiao, Zhongchen Li, Zhiqiang Wang, Cheng Huang, Guoming Shi, Aiwu Ke, Luman Wang, Ying Fu, Jie Xia, Haoyu Wen, Jian Zhou, Xiaoying Wang, Dan Ye, Jia Fan, Yiwei Chu, Jiabin Cai. Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma. Hepatology 2023; 77(3): 745 doi: 10.1002/hep.32442
|
| 124 |
Qian Xu, Huiya Ying, Chunming Xie, Rong Lin, Yangjin Huang, Ruhuang Zhu, Yuejuan Liao, Yuan Zeng, Fujun Yu. Characterization of neutrophil extracellular traps related gene pair for predicting prognosis in hepatocellular carcinoma. The Journal of Gene Medicine 2023; 25(11) doi: 10.1002/jgm.3551
|
| 125 |
Shun Zhou, Jian Xu, Dong Wang, Yong Wang, Lijuan Meng, Song Cao. Development an Immune-Related MicroRNA Risk Index in Hepatocellular Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5224434
|
| 126 |
Siyuan Song, Peng Shu. Expression of ferroptosis-related gene correlates with immune microenvironment and predicts prognosis in gastric cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-12800-6
|
| 127 |
Indranil Banerjee, Paul B. Fisher, Devanand Sarkar. . Advances in Cancer Research 2021; 152: 329 doi: 10.1016/bs.acr.2021.05.003
|